Paul Rickard takes a deep dive into infrastructure and how you can invest in the sector and is also joined by ST Wong of Prime Value, and Arjun Paliwal of InvestorKit.

Paul Rickard shares his thoughts on the major current affairs impacting financial markets and the economy.

Paul Rickard takes a look at the winners and losers for Monday, and is joined by Raymond Chan of Morgans, and Ron Shamgar of TAMIM Asset Management.

Dr Ross explains how a cytokine storm is caused due to COVID19 and looks at a possible monoclonal antibody that can help improve symptoms.

Paul Rickard is joined by Michael Gable of Fairmont Equities, and Angus Moore of PropTrack, while Peter Switzer is joined by property expert Margaret Lomas, and also gives his take on what he's seeing in the market right now.

Paul Rickard shares his thoughts on the major current affairs impacting financial markets and the economy.

Dr Ross explores the three cardinal symptoms of long Covid - fatigue, brain fog and shortness of breath.

Paul Rickard is joined by Peter Switzer, Ausbil's Head of Equities, Paul Xiradis, Marcus Bogdan of Blackmore Capital, and Paul Ryan of REA Group.

Paul Rickard shares his thoughts on the major current affairs impacting financial markets and the economy.

Paul Rickard speaks with Adam Dawes of Shaw and Partners, while Peter Switzer is joined by Chief Economist at Morgans, Michael Knox, and Head of Investments at Nucleus Wealth, Damien Klassen.

Dr Ross discusses two effective antivirals for Long COVID that has a 90% reduction in hospitalisation and covid related deaths.

Peter Switzer is joined by Rudi Filapek-Vandyck of FNArena, Paul Rickard from the Switzer Report, and Paul Miron from Msqaured Capital.